Clinical Trials. Questo articolo non è disponibile.
12 valutazioni di Goodreads
Lingua: inglese
Editore: Elsevier Science, 2016
- Rilegato
- Nuovo

Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US
Venditore con 5 stelle
Venditore AbeBooks dal 7 aprile 2005
Non disponibile
Rilegato
Condizione: Nuovo
EUR 105,79
Descrizione dell’articolo da parte del venditore
New Book. Shipped from UK. Established seller since 2000.
Codice articolo GB-9780128042175
- Titolo
- Clinical Trials
- Autore
- Tom Brody
- Editore
- Elsevier Science
- Anno di pubblicazione
- 2016
- Condizione
- New
- Rilegatura
- HRD
- Lingua
- inglese
- ISBN 10
- 0128042176
- ISBN 13
- 9780128042175
- Edizione
- seconda edizione
- Peso dell'articolo
- 2043 grammi
Clinical Trials, Second Edition, offers those engaged in clinical trial design a valuable and practical guide. This book takes an integrated approach to incorporate biomedical science, laboratory data of human study, endpoint specification, legal and regulatory aspects and much more with the fundamentals of clinical trial design. It provides an overview of the design options along with the specific details of trial design and offers guidance on how to make appropriate choices. Full of numerous examples and now containing actual decisions from FDA reviewers to better inform trial design, the 2nd edition of Clinical Trials is a must-have resource for early and mid-career researchers and clinicians who design and conduct clinical trials.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Dr. Tom Brody received his PhD from the University of California at Berkeley in 1980, and conducted postdoctoral research at University of Wisconsin-Madison and also at U.C. Berkeley. His 20 research publications concern the metabolism and pharmacology of folates, cloning an anti-cancer gene (XPE gene), and the structure of an antibody (natalizumab) used for treating multiple sclerosis. The author has 15 years of pharmaceutical industry experience, acquired at Schering-Plough, Cerus Corporation, and Elan Pharmaceuticals, and has contributed to FDA submissions for the indications of multiple sclerosis, melanoma, head and neck cancer, liver cancer, pancreatic cancer, and hepatitis C. At an earlier time, he wrote two editions of Clinical Trials, published by Elsevier, Inc. The author has 16 years of training and experience in the Code of Federal regulations, as it applies to pharmaceuticals and clinical trial design.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.